Data from Moving Closer to a Prognostic DNA Methylation Signature in Colon Cancer

<div>Abstract<p>Although large panels of genes undergoing aberrant CpG island methylation in colorectal cancer have been identified, reliable predictors for clinical management in this tumor type remain elusive. A new DNA methylation signature affecting the extracellular matrix (ECM) pathway has been identified with potential prognostic value in colon cancer. <i>Clin Cancer Res; 17(6); 1215–7. ©2011 AACR</i>.</p></div>